trending Market Intelligence /marketintelligence/en/news-insights/trending/gkkxxim9xwsmmlmw22plng2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

UDG Healthcare adds board member

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates


UDG Healthcare adds board member

UDG Healthcare plc added Erik Van Snippenberg to its board as a nonexecutive director.

Snippenberg was most recently with GlaxoSmithKline Plc as senior vice president and area head for Europe and Canada. He was also a member of GlaxoSmithKline's global pharmaceutical management team.

Meanwhile, UDG Healthcare said Chris Corbin, a nonexecutive director of the company due to retire on April 2019, has agreed to extend his term. Corbin will be subject to re-election at the company's annual general meeting.

The Dublin-based company provides clinical, commercial, communication and packaging services to the healthcare industry.